The latest thoracic oncology news
Deep learning may help doctors choose better lung cancer treatments
Doctors and healthcare workers may one day use a machine learning model, called deep learning,…
Browsing: Lung Cancer
Adding ipilimumab to pembrolizumab does not improve efficacy in patients with NSCLC
Adding ipilimumab to pembrolizumab does not improve efficacy and is associated with greater toxicity than…
Potential combined drug therapy for lung cancer
Most lung cancers are of a type called non-small-cell lung carcinoma (NSCLC). This type of…
New combination of immunotherapies shows great promise for treating lung cancer
McMaster University (Canada) researchers have established in lab settings that a novel combination of two…
Record drop in cancer mortality for second straight year due to improved lung cancer treatment
Overall cancer death rates in the United States dropped continuously from 1991 through 2018 for…
Potential treatment for an aggressive form of lung cancer
Researchers at the Children’s Medical Center Research Institute at UT Southwestern (CRI), USA, have discovered…
Study: the pandemic’s impact on lung cancer
When the pandemic hit the U.S. in early 2020, many routine activities came to a…
Study reports drop in lung cancer screening, rise in malignancy during COVID-19 surge
The current surge in coronavirus disease 2019 (COVID-19) cases poses challenges for providers and institutions…
Drugs create balancing act for patients with non-small cell lung cancer
The results of a large, retrospective study of patients who received a form of immunotherapy…
Unexpected finding reveals new target for aggressive form of lung cancer
Targeted therapies are currently available for about one-third of people with lung adenocarcinoma, the most…